SBIO vs. FDMO
SBIO (ALPS Medical Breakthroughs ETF) and FDMO (Fidelity Momentum Factor ETF) are both exchange-traded funds - SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index, while FDMO is a Momentum fund tracking the Fidelity U.S. Momentum Factor Index. Both are passively managed. Over the past 5 years, SBIO returned 4.73%/yr vs 15.56%/yr for FDMO. A 0.54 correlation means they provide meaningful diversification when combined. SBIO charges 0.50%/yr vs 0.29%/yr for FDMO.
Performance
SBIO vs. FDMO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO achieves a 18.79% return, which is significantly higher than FDMO's 13.91% return.
SBIO
- 1D
- 2.88%
- 1M
- 14.15%
- YTD
- 18.79%
- 6M
- 15.02%
- 1Y
- 98.14%
- 3Y*
- 25.22%
- 5Y*
- 4.73%
- 10Y*
- 11.54%
FDMO
- 1D
- -0.47%
- 1M
- 1.67%
- YTD
- 13.91%
- 6M
- 11.69%
- 1Y
- 28.77%
- 3Y*
- 27.46%
- 5Y*
- 15.56%
- 10Y*
- —
SBIO vs. FDMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 18.79% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
FDMO Fidelity Momentum Factor ETF | 13.91% | 21.43% | 32.78% | 24.79% | -19.32% | 22.23% | 21.71% | 25.29% | -4.13% | 23.93% |
Correlation
The correlation between SBIO and FDMO is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.43 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.47 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.52 |
Correlation (All Time) Calculated using the full available price history since Sep 15, 2016 | 0.54 |
The correlation between SBIO and FDMO shifts across timeframes, from 0.43 (1 year) to 0.54 (all time), reflecting how their relationship changes across market environments.
SBIO vs. FDMO - Sectors Allocation Comparison
Sectors
SBIO
FDMO
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Financial Services
Healthcare
SBIO
FDMO
Basic Materials
SBIO
-
FDMO
Communication Services
SBIO
-
FDMO
Consumer Cyclical
SBIO
-
FDMO
Consumer Defensive
SBIO
-
FDMO
Energy
SBIO
-
FDMO
Industrials
SBIO
-
FDMO
Real Estate
SBIO
-
FDMO
Technology
SBIO
-
FDMO
Utilities
SBIO
-
FDMO
Financial Services
SBIO
FDMO
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. FDMO — Risk / Return Rank
SBIO
FDMO
SBIO vs. FDMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Fidelity Momentum Factor ETF (FDMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBIO | FDMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.62 | ||
| Sortino ratioReturn per unit of downside risk | +1.88 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.29 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 7.80 | 2.37 | +5.43 |
| Martin ratioReturn relative to average drawdown | 21.75 | 9.22 | +12.53 |
Loading charts...
Drawdowns
SBIO vs. FDMO - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than FDMO's maximum drawdown of -33.94%. Use the drawdown chart below to compare losses from any high point for SBIO and FDMO.
Loading charts...
Drawdown Indicators
| SBIO | FDMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -33.94% | -29.12% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | -12.22% | -0.44% |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | -21.88% | -20.56% |
Max Drawdown (5Y)Largest decline over 5 years | -53.10% | -25.44% | -27.66% |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | — | — |
Current DrawdownCurrent decline from peak | -0.77% | -3.26% | +2.49% |
Average DrawdownAverage peak-to-trough decline | -28.36% | -5.40% | -22.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 3.13% | +1.40% |
Volatility
SBIO vs. FDMO - Volatility Comparison
ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 11.21% compared to Fidelity Momentum Factor ETF (FDMO) at 7.78%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than FDMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO | FDMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 7.78% | +3.43% |
Volatility (6M)Calculated over the trailing 6-month period | 23.75% | 14.53% | +9.22% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.51% | 17.86% | +12.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.76% | 19.25% | +14.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.20% | 19.58% | +13.62% |
SBIO vs. FDMO - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is higher than FDMO's 0.29% expense ratio.
Dividends
SBIO vs. FDMO - Dividend Comparison
SBIO has not paid dividends to shareholders, while FDMO's dividend yield for the trailing twelve months is around 0.60%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
FDMO Fidelity Momentum Factor ETF | 0.60% | 0.61% | 0.90% | 0.87% | 1.19% | 0.60% | 0.77% | 1.23% | 1.22% | 1.09% | 0.45% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% |
Frequently Asked Questions
SBIO and FDMO have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (11.21%) compared to FDMO (7.78%). In terms of maximum drawdown, SBIO dropped -63.06% vs FDMO's -33.94%.
On 5-year performance, FDMO leads with 15.56% vs 4.73% for SBIO. On fees, FDMO is cheaper at 0.29% per year. On volatility, FDMO has been the lower-risk option at 7.78%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FDMO has performed better with a 15.56% return vs 4.73%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FDMO is cheaper with a 0.29% expense ratio, compared with 0.50% for SBIO.
FDMO has the higher dividend yield at 0.60%, compared with 0.00% for SBIO.
SBIO is categorized as Health & Biotech Equities, while FDMO is Momentum. SBIO tracks S-Network Medical Breakthroughs Index, while FDMO tracks Fidelity U.S. Momentum Factor Index. They also come from different issuers: SS&C and Fidelity. Their fees differ too: 0.50% for SBIO and 0.29% for FDMO.
SBIO currently has the higher Sharpe Ratio (3.24 vs 1.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SBIO and FDMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer